AF
Affimed
AFMD·NASDAQHeidelberg DEFounded 2000150 employees
Micro CapbiotechPublicOncologyHematology
Platform: AFM13 NK Engager
Market Cap
$0.03B
All Drugs
2
Clinical Trials
3
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (AFMD)
Loading AFMD stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Sematuximab | AFM-3975 | Phase 2/3 | 2 | FXIa | MyelofibrosisPsA | ||
| Rilusertib | AFM-3717 | Phase 3 | 1 | HER2 | CeliacCrohn's |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)